Nurix therapeutics to participate in upcoming investor conferences

San francisco, may 11, 2021 (globe newswire) -- nurix therapeutics, inc. (nasdaq: nrix), a biopharmaceutical company developing targeted protein modulation drugs, today announced that members of nurix management team will participate in the following conferences in may:

NRIX Ratings Summary

NRIX Quant Ranking